New award for trastuzumab with amgen. Ordering period is NOV 15, 2025 through NOV 14, 2026 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0053
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Trastuzumab and Biosimilars Pre-Solicitation · 36E79725R0038 · Posted May 1, 2025
- Last date to order 92% complete
- IDV ceiling
- $15,375,050.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Amgen USA Inc. on November 15, 2025, with a ceiling value of $15,375,050 for the supply of Trastuzumab and biosimilar products. The ordering period runs from November 15, 2025, through November 14, 2026, with four one-year options available.
Performance occurs at Amgen USA manufacturing facilities. The contract supports multiple federal customers: the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Distribution channels are the VA and DoD Pharmaceutical Prime Vendor Programs.
The originating solicitation called for two Trastuzumab formulations: 150 milligrams per vial (estimated 10,297 annual vials) and 420 milligrams per vial (estimated 1,426 annual vials). Offerors were required to provide FDA-licensed biosimilar products listed in the FDA Purple Book, with exact drug names and unique NDC numbers. The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). No set-aside applied. The contract represents a modification to update the manufacturing place of performance for existing national contract 36E79725D0053.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0053?
36E79725D0053 was awarded to Amgen USA Inc. by National Acquisition Center (Headquarters) on November 15, 2025.
How much is contract 36E79725D0053 worth?
36E79725D0053's own ceiling is $15,375,050.
Who can order from contract 36E79725D0053?
36E79725D0053 is a single award indefinite delivery contract.
Was contract 36E79725D0053 competed?
The extent of competition for 36E79725D0053 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV